Asthma is a respiratory condition that requires individualized care, considering each patient’s unique characteristics and therapeutic opportunities. Both primary care professionals and specialists ...

Asthma affects millions of people across the country, including over 4 million kids. Using asthma medicines correctly is ...

Breztri Aerosphere is a single-inhaler fixed-dose triple therapy that combines budesonide, glycopyrrolate, and formoterol fumarate.

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...

For World Asthma Day, GINA is spotlighting the need for greater access to inhaled corticosteroids for everyone, from adults ...

Breztri becomes the first single-inhaler triple therapy for patients as young as 12 years ...

AstraZeneca’s fixed-dose triple-combination therapy BREZTRI Aerosphere ® (budesonide/glycopyrrolate/formoterol fumarate or BGF 320/36/9.6μg) has been approved in ...